Clinical Trials Directory

Trials / Completed

CompletedNCT07278349

Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) Tablets

Randomized, Single Dose, Two-Way Crossover, Open Label Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) Tablets an Oral Administration to Healthy Adults Under Fasting Conditions

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Humanis Saglık Anonim Sirketi · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Randomized, Single Dose, Two-Way Crossover, Open Label bioequivalence study to compare Vonoprazan 20 mg Film Coated Tablets versus Voquezna® 20 mg (Vonoprazan) Tablets an oral administration to healthy adults under fasting conditions

Conditions

Interventions

TypeNameDescription
DRUGVonoprazan Tablets1 tablet of 20 mg Vonoprazan
DRUGVOQUEZNA® Tablets1 tablet of 20 mg Vonoprazan

Timeline

Start date
2025-09-21
Primary completion
2025-10-04
Completion
2025-12-09
First posted
2025-12-12
Last updated
2025-12-12

Locations

1 site across 1 country: Jordan

Source: ClinicalTrials.gov record NCT07278349. Inclusion in this directory is not an endorsement.